Wee Joo Chng
Agency for Science, Technology and Research(SG)National University of Singapore(SG)Nanyang Technological University(SG)Singapore College of Traditional Chinese Medicine(SG)National University Cancer Institute, Singapore(SG)Michigan Cancer Research Consortium(US)Duke-NUS Medical School(SG)A*STAR-NUS Clinical Imaging Research Centre(SG)National Cancer Centre Singapore(SG)National University Hospital(SG)Clinical Research Consortium(US)National University Health System(SG)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Peptidase Inhibition and Analysis
Most-Cited Works
- → The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms(2022)3,646 cited
- → The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms(2022)3,464 cited
- → International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma(2016)2,897 cited
- → Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma(2007)983 cited
- → Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group(2016)914 cited
- → Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study